Natera Inc Stock
Your prediction
Natera Inc Stock
There is an upward development for Natera Inc compared to yesterday, with an increase of €6.00 (3.000%).
Pros and Cons of Natera Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Natera Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Natera Inc | 3.000% | -2.913% | 11.732% | 25.786% | 31.579% | 434.759% | - |
| Atricure Inc. | 2.420% | 10.000% | 20.438% | -46.774% | -46.774% | -46.774% | -14.948% |
| Orasure Tech | 0.940% | -1.852% | 6.000% | -42.703% | -38.012% | -56.017% | -79.615% |
| SI-BONE Inc | -1.860% | -1.829% | 20.149% | 21.053% | 23.846% | - | - |
News
Natera (NTRA) Q2 Revenue Jumps 32%
Natera (NASDAQ:NTRA), a leader in genetic testing across oncology, women's health, and organ health, reported its earnings for Q2 2025 on August 7, 2025. The most significant news was a 32.2%
